Alpha Windward’s Emergent Biosolutions EBS Stock Holding History

Alpha Windward’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-114	Closed	-$12K	–	100
2020 Q3	$12K	Sell	114 -62	-35%	-$6.68K	0.01%	334
2020 Q2	$14K	Buy	+176	New	+$13.1K	0.01%	350

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Alpha Windward's EBS Position: Q4 2020 in Review

Alpha Windward sold out of Emergent Biosolutions (EBS) in Q4 2020, closing a stake of 114 shares — an estimated $12K sold.

Alpha Windward first reported a position in EBS in Q2 2020 and held it in 2 quarters. The position peaked at $14K in Q2 2020. 353 funds tracked by Wall St. Rank hold EBS as of Q4 2020.

Alpha Windward reported no remaining Emergent Biosolutions position as of Q4 2020 after selling out during the quarter.
Alpha Windward sold 114 Emergent Biosolutions shares in Q4 2020, an estimated $12K.
Alpha Windward first reported a position in Emergent Biosolutions in Q2 2020 and held it in 2 quarters.
Alpha Windward's Emergent Biosolutions position peaked at $14K in Q2 2020.
353 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2020.

Based on Alpha Windward's 13F filing for Q4 2020.